Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (315)	4/9/2002 11:28:03 PM
From: Jibacoa	Respond to of 544

INMX Seems to have found support at the 1.25 level.<g> It still has to close above 1.40 before testing the resistance at 1.62.<g> siliconinvestor.com But with some help it can get back to the 2 level or even test the 2.25 resistance from its Ls in late January.<g> siliconinvestor.com IMNX has several interesting points (besides its bioinformatic software for the analysis of genomic, proteomic and other biomolecular data.<g>) The insiders hold 74% and institutions 39% (149% of the float)and had been buying some lately. INMX reportedly has $2.50 cash/share and has been selling around 0.4 of book.<g> The short ratio is around 18% of the float (about 6.5x the average daily volume)<g> At any rate, it seems that the R/R is favorable at present levels.<g> Bernard